<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: This paper reports relationships between symptoms assessed using a newly developed instrument for assessing patient-reported symptoms, the Modified Ambulatory Care Flow Sheet (MACFS), and other symptom assessment measures </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Using a cross-sectional design, patients on active treatment for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> were recruited in an ambulatory setting of a tertiary care <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> center in western Canada </plain></SENT>
<SENT sid="2" pm="."><plain>Participants completed the European Organization for Research and Treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Quality of Life Questionnaire--<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 30, the Rotterdam Symptom Checklist Modified, Linear analog scales for pain and coping, and the MACFS, <z:hpo ids='HP_0000001'>all</z:hpo> at a single time point </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We found moderate to strong correlations between the MACFS scores and scores on the other symptom measures used </plain></SENT>
<SENT sid="4" pm="."><plain>The correlations were not as strong when using the MACFS symptom change scores, as when using the MACFS scores for the presence or absence of a particular symptom </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The MACFS reflects the symptom experience of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Further evaluation in more diverse populations and of the relationship between MACFS symptom scores and quality of life will improve our understanding of the MACFS and of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patient treatment experience </plain></SENT>
</text></document>